Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $11,363 | 653 | 99.3% |
| Gift | $71.52 | 1 | 0.6% |
| Education | $13.76 | 1 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $5,360 | 328 | $0 (2024) |
| Gilead Sciences, Inc. | $900.80 | 51 | $0 (2023) |
| Takeda Pharmaceuticals U.S.A., Inc. | $743.93 | 39 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $511.96 | 26 | $0 (2024) |
| PFIZER INC. | $504.61 | 25 | $0 (2024) |
| Valeant Pharmaceuticals North America LLC | $372.48 | 16 | $0 (2017) |
| Janssen Biotech, Inc. | $329.74 | 17 | $0 (2024) |
| Ferring Pharmaceuticals Inc. | $265.69 | 13 | $0 (2023) |
| INTERCEPT PHARMACEUTICALS, INC. | $243.47 | 13 | $0 (2023) |
| Allergan Inc. | $223.31 | 17 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,311 | 66 | ABBVIE INC. ($435.35) |
| 2023 | $1,262 | 74 | AbbVie Inc. ($692.05) |
| 2022 | $1,645 | 83 | ABBVIE INC. ($1,056) |
| 2021 | $1,690 | 89 | AbbVie Inc. ($1,009) |
| 2020 | $1,066 | 58 | AbbVie Inc. ($675.56) |
| 2019 | $1,645 | 105 | AbbVie, Inc. ($624.24) |
| 2018 | $1,195 | 75 | AbbVie, Inc. ($353.20) |
| 2017 | $1,635 | 105 | AbbVie, Inc. ($514.33) |
All Payment Transactions
655 individual payment records from CMS Open Payments — Page 1 of 27
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $3.21 | General |
| Category: IMMUNOLOGY | ||||||
| 12/17/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $19.38 | General |
| Category: IMMUNOLOGY | ||||||
| 12/11/2024 | PFIZER INC. | XELJANZ (Drug), VELSIPITY | Food and Beverage | In-kind items and services | $25.62 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 12/03/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $30.26 | General |
| Category: Immunology | ||||||
| 11/18/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $20.23 | General |
| Category: IMMUNOLOGY | ||||||
| 11/14/2024 | PFIZER INC. | XELJANZ (Drug), VELSIPITY | Food and Beverage | In-kind items and services | $26.54 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 11/11/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $6.95 | General |
| Category: IMMUNOLOGY | ||||||
| 11/08/2024 | ABBVIE INC. | — | Food and Beverage | In-kind items and services | $29.31 | General |
| 11/06/2024 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $3.41 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/31/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $7.38 | General |
| Category: IMMUNOLOGY | ||||||
| 10/29/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $16.09 | General |
| Category: Immunology | ||||||
| 10/25/2024 | Madrigal Pharmaceuticals | RESMETIROM (Drug) | Food and Beverage | In-kind items and services | $34.63 | General |
| Category: LIVER DISEASE | ||||||
| 10/24/2024 | EVOKE PHARMA, INC. | GIMOTI (Drug) | Food and Beverage | In-kind items and services | $20.41 | General |
| Category: Gastroenterology | ||||||
| 10/23/2024 | ABBVIE INC. | VIBERZI (Drug), CREON | Food and Beverage | In-kind items and services | $7.81 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/18/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $23.91 | General |
| Category: IMMUNOLOGY | ||||||
| 10/17/2024 | PFIZER INC. | XELJANZ (Drug), VELSIPITY | Food and Beverage | In-kind items and services | $26.88 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 10/10/2024 | Lilly USA, LLC | OMVOH (Drug) | Food and Beverage | In-kind items and services | $33.09 | General |
| Category: Immunology | ||||||
| 09/24/2024 | PFIZER INC. | XELJANZ (Drug), VELSIPITY | Food and Beverage | In-kind items and services | $26.35 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 09/19/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $20.64 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 09/18/2024 | Lilly USA, LLC | OMVOH (Drug) | Food and Beverage | In-kind items and services | $30.64 | General |
| Category: Immunology | ||||||
| 09/17/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $22.14 | General |
| Category: IMMUNOLOGY | ||||||
| 08/20/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $32.79 | General |
| Category: INTERNAL MEDICINE | ||||||
| 08/19/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $23.12 | General |
| Category: IMMUNOLOGY | ||||||
| 08/13/2024 | PFIZER INC. | XELJANZ (Drug), VELSIPITY | Food and Beverage | In-kind items and services | $27.25 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 08/13/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $7.55 | General |
| Category: IMMUNOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 14 | 501 | 533 | $299,865 | $57,226 |
| 2022 | 14 | 496 | 528 | $283,890 | $55,959 |
| 2021 | 15 | 563 | 598 | $302,080 | $64,343 |
| 2020 | 16 | 521 | 577 | $292,875 | $61,798 |
All Medicare Procedures & Services
59 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2023 | 79 | 79 | $75,050 | $12,266 | 16.3% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2023 | 33 | 33 | $52,800 | $6,975 | 13.2% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 72 | 73 | $49,275 | $5,394 | 10.9% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2023 | 28 | 28 | $25,200 | $5,316 | 21.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 42 | 42 | $14,700 | $5,107 | 34.7% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 50 | 54 | $8,100 | $3,540 | 43.7% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 48 | 48 | $13,920 | $3,402 | 24.4% |
| 45378 | Diagnostic exam of large bowel using a flexible endoscope | Facility | 2023 | 22 | 22 | $20,900 | $3,321 | 15.9% |
| G0121 | Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 2023 | 16 | 16 | $12,800 | $3,043 | 23.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 28 | 29 | $5,800 | $2,531 | 43.6% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 31 | 54 | $4,320 | $2,218 | 51.3% |
| 43248 | Insertion of guide wire with dilation of esophagus using a flexible endoscope | Facility | 2023 | 14 | 14 | $9,450 | $1,609 | 17.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 26 | 27 | $4,050 | $1,462 | 36.1% |
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Office | 2023 | 12 | 14 | $3,500 | $1,043 | 29.8% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2022 | 64 | 65 | $59,700 | $10,298 | 17.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 56 | 56 | $18,525 | $6,761 | 36.5% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2022 | 35 | 35 | $30,300 | $6,589 | 21.7% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2022 | 32 | 32 | $50,300 | $6,569 | 13.1% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 64 | 64 | $43,200 | $4,719 | 10.9% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 55 | 55 | $15,050 | $4,024 | 26.7% |
| G0121 | Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 2022 | 21 | 21 | $16,200 | $4,016 | 24.8% |
| 45378 | Diagnostic exam of large bowel using a flexible endoscope | Facility | 2022 | 23 | 24 | $21,250 | $3,540 | 16.7% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 43 | 43 | $6,350 | $2,499 | 39.3% |
| 99231 | Follow-up hospital inpatient care per day, typically 15 minutes | Facility | 2022 | 37 | 63 | $5,040 | $1,963 | 39.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 24 | 28 | $4,200 | $1,718 | 40.9% |
About Dr. Gregory Ardigo, M.D
Dr. Gregory Ardigo, M.D is a Specialist healthcare provider based in Murrieta, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/30/2006. The National Provider Identifier (NPI) number assigned to this provider is 1548353956.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Gregory Ardigo, M.D has received a total of $11,449 in payments from pharmaceutical and medical device companies, with $1,311 received in 2024. These payments were reported across 655 transactions from 37 companies. The most common payment nature is "Food and Beverage" ($11,363).
As a Medicare-enrolled provider, Ardigo has provided services to 2,081 Medicare beneficiaries, totaling 2,236 services with total Medicare billing of $239,326. Data is available for 4 years (2020–2023), covering 59 distinct procedure/service records.
Practice Information
- Specialty Specialist
- Location Murrieta, CA
- Active Since 09/30/2006
- Last Updated 07/09/2007
- Taxonomy Code 174400000X
- Entity Type Individual
- NPI Number 1548353956
Products in Payments
- RINVOQ (Biological) $1,098
- HUMIRA (Biological) $1,071
- Humira (Biological) $841.99
- LINZESS (Drug) $817.15
- XIFAXAN (Drug) $541.69
- XELJANZ (Drug) $504.61
- ENTYVIO (Biological) $455.64
- Creon (Drug) $425.50
- SKYRIZI (Biological) $394.20
- MAVYRET (Drug) $304.29
- STELARA (Biological) $263.35
- DUPIXENT (Biological) $260.92
- CLENPIQ (Drug) $215.20
- DIFICID (Drug) $189.09
- Sucraid (Drug) $165.84
- OCALIVA (Drug) $165.35
- CREON (Drug) $161.74
- VIBERZI (Drug) $156.12
- Mavyret (Drug) $147.18
- OMVOH (Drug) $146.41
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Specialist Doctors in Murrieta
Mr. Victor Nguyen, Md, MD
Specialist — Payments: $11,205
Dennis Kim, M.d, M.D
Specialist — Payments: $7,970
Dr. Chawki Harfouch, M.d, M.D
Specialist — Payments: $7,561
Brian Bui, M.d, M.D
Specialist — Payments: $7,358
Dr. James Neal, M.d, M.D
Specialist — Payments: $4,230
Dr. Lawrence Hurwitz, M.d, M.D
Specialist — Payments: $3,719